Amway (Malaysia) Holdings Bhd expects cautious consumer spending to continue affecting its sales performance for the remainder of 2026 as households remain careful with their purchases. The company said it would maintain its focus on the health and wellbeing sector while adapting its business strategies to changing consumer preferences and challenging market conditions.
Amway Malaysia Prioritises Health Products and Digital Investments Amid Softer Consumer Demand
In its latest Bursa Malaysia filing, the group said it would emphasise science-backed products supporting healthy ageing and long-term wellbeing. It also plans disciplined investments to strengthen sales capabilities, encourage product innovation and improve its digital and physical infrastructure. Despite weaker demand, the company expects profitability to stabilise through prudent investments and product price adjustments.
For the third quarter ended September 30, 2026, Amway recorded a net profit of RM12.07 million, down from RM14.62 million a year earlier.
Revenue also declined to RM258.28 million from RM275.55 million, partly due to a higher comparative base following a cellular health product launch in September 2025. For the first nine months, net profit fell to RM26.49 million, while revenue dropped to RM792.07 million. The board also declared a third interim dividend of five sen per share.
Amway Malaysia faces softer sales as cautious consumer spending continues to affect household purchasing decisions.
#latestmalaysia
Table of Contents
Read More News on Latest Malaysia
Follow us on:
Read More News on Business News Malaysia
Read More News on SG Business News
Read More News on World Future TV

